<DOC>
	<DOCNO>NCT01396161</DOCNO>
	<brief_summary>The primary purpose study evaluate safety , tolerability , pharmacokinetics pharmacodynamics multiple ascend dos PF-05175157 healthy volunteer patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>A Study PF-05175157 Healthy Volunteers Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . In addition , subject must normal pulmonary function test normal ocular examination . Body Mass Index ( BMI ) 25.5 35.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Women must nonchildbearing potential . Subjects type 2 diabetes : HbA1c ≥7.0 % ≤10.0 % metformin , ≥6.5 % ≤9.0 % patient require washedoff SU DPP4i . For subject type 2 diabetes , due possible effect disposition , CYP P450 3A4/5 2D6 substrate coadministered study medication . Evidence history clinically significant hematological , renal , endocrine , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic seasonal allergy time dose ) . Evidence history chronic ongoing current pulmonary disease . History smoke past 5 year history smoke 10 pack year , history evidence habitual use ( non smoke ) tobacco nicotine containing product within 3 month Screening , positive cotinine test Screening Day 3 . Active ocular disease include infection , glaucoma , seasonal allergy , dry eye symptom retinal/optic nerve disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Multiple Doses</keyword>
	<keyword>Safety</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Type 2 Diabetic Patients</keyword>
</DOC>